AG
GOSS icon

Advisor Group’s Gossamer Bio GOSS Stock Holding History

Advisor Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$14K Buy
917
+317
+53% +$6.38K ﹤0.01% 4147
2019
Q3 		$10K Buy
600
+300
+100% +$5.96K ﹤0.01% 4335
2019
Q2 		$7K Buy
+300
New +$5.74K ﹤0.01% 4537

Other funds holding GOSS

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Advisor Group's GOSS Position: Q4 2019 in Review

Advisor Group increased its Gossamer Bio (GOSS) stake by 53% in Q4 2019, buying an estimated $6.38K and bringing the position to 917 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #4147.

Advisor Group first reported a position in GOSS in Q2 2019 and has held it in 3 quarters since. 88 funds tracked by Wall St. Rank hold GOSS as of Q4 2019.

  • Advisor Group held 917 shares of Gossamer Bio worth $14K as of Q4 2019.
  • Advisor Group bought 317 Gossamer Bio shares in Q4 2019, an estimated $6.38K.
  • Gossamer Bio made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4147 holding.
  • Advisor Group first reported a position in Gossamer Bio in Q2 2019 and has held it in 3 quarters since.
  • 88 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.